Overview
- British cardiologist Aseem Malhotra, a close ally of HHS Secretary Robert F. Kennedy Jr., told The Daily Beast the administration may seek to remove COVID-19 shots from the U.S. market “within months.”
- Malhotra says he plans to brief President Trump in September and points to a disputed 2022 Vaccine journal analysis of “excess serious adverse events” as the basis for the push.
- The White House responded that any discussion of such a move is baseless speculation and reaffirmed reliance on rigorous scientific evidence for health policy.
- Legal and regulatory experts emphasize that a president cannot unilaterally withdraw licensed vaccines, noting the FDA’s authority and the likelihood of court challenges.
- Beyond the rumor, HHS has already ended roughly $500 million across 22 mRNA vaccine projects and reworked vaccine advisory and recommendation policies, prompting a public letter of protest from more than 750 current and former CDC, HHS, and NIH staff.